Read more

December 01, 2023
1 min read
Save

Top in allergy/asthma: Medical waivers for military enlistment; allergy info on Instagram

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Having a history of asthma or allergy may disqualify candidates from enlisting in the military. However, candidates can work with their allergists to provide documentation that will support a medical waiver, an expert said.

“The medical documentation that you provide ... is going to help our patients streamline that process,” Karla Adams, MD, FACAAI, an associate professor of pediatrics at Uniformed Services University, said during her presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

US Army soldiers
Having a history of asthma or allergy may disqualify candidates from enlisting in the military. However, candidates can work with their allergists to provide documentation that will support a medical waiver, an expert said. Image source: Adobe Stock

It was the top story in allergy/asthma last week.

Another top story was about an Instagram campaign that provided valuable information about allergens, nutrition labels, autoinjector use and more to thousands of users in just 3 weeks.

Read these and more top stories in allergy/asthma below:

Allergists can guide patients through medical waivers in military enlistment

Allergists can help adolescents and young adults with atopic conditions enlist in the military, a presenter said. Read more.

Instagram can connect patients with accurate food allergy information

Physicians can use Instagram to connect with patients and provide accurate and valuable information, according to researchers. Read more.

Remibrutinib confers fast symptom improvement in chronic spontaneous urticaria

Patients with inadequately controlled chronic spontaneous urticaria experienced relief of symptoms after only 2 weeks of treatment with remibrutinib (Novartis), according to data from the ongoing REMIX-1 and REMIX-2 studies. Read more.

FDA grants fast track designation to multi-food oral immunotherapy

The FDA has granted fast track designation to ADP101, an oral immunotherapy designed to simultaneously treat one or more of the most common food allergies, Alladapt Immunotherapeutics announced in a press release. Read more.

Patients associate their food allergy development with multiple factors

Patients may associate their food allergy with diet, genetics, family history and infection, data show. Read more.